A detailed history of Woodline Partners LP transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Woodline Partners LP holds 670,807 shares of FULC stock, worth $2.23 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
670,807
Previous 501,301 33.81%
Holding current value
$2.23 Million
Previous $3.11 Million 22.97%
% of portfolio
0.02%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$3.18 - $9.74 $539,029 - $1.65 Million
169,506 Added 33.81%
670,807 $2.39 Million
Q2 2024

Aug 14, 2024

BUY
$5.98 - $9.31 $3 Million - $4.67 Million
501,301 New
501,301 $3.11 Million
Q2 2023

Aug 14, 2023

BUY
$2.26 - $3.8 $1.35 Million - $2.27 Million
596,695 New
596,695 $1.97 Million

Others Institutions Holding FULC

About Fulcrum Therapeutics, Inc.


  • Ticker FULC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,038,900
  • Market Cap $173M
  • Description
  • Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...
More about FULC
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.